missing translation for 'onlineSavingsMsg'
Learn More

Tocris Bioscience™ GRL 0617

Catalog No. 728025
Change view
Click to view available options
Quantity:
25 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
728025 25 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 728025 Supplier Tocris Bioscience™ Supplier No. 7280/25

Coronavirus PLpro inhibitor

GRL 0617 is a coronavirus papain-like protease (Plpro) inhibitor (IC50 values are 0.6 and 0.8 μM for SARS-COV and SARS-CoV-2 PLpro, respectively). Inhibits deubiquitination activity of SARS-CoV PLpro. Displays no inhibition of human deubiquitinating enzymes. Improves cell viability following SARS-CoV infection. Inhibits SARS-CoV-2 viral replication and induces antiviral immune signaling pathways following SARS-CoV-2 infection in CaCo-2 cells.

Specifications

Chemical Name or Material 5-Amino-2-methyl-N-[(1 R)-1-(1-naphthalenyl)ethyl]benzamide
CAS 1093070-16-6
Quantity 25 mg
Target Papain-like Protease Inhibitors
Molecular Formula C20H20N2O
Purity 0.98